A

Apogee Therapeutics Inc
NASDAQ:APGE

Watchlist Manager
Apogee Therapeutics Inc
NASDAQ:APGE
Watchlist
Price: 36.64 USD -2.77% Market Closed
Market Cap: 2.2B USD

Wall Street
Price Targets

APGE Price Targets Summary
Apogee Therapeutics Inc

Wall Street analysts forecast APGE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APGE is 95.37 USD with a low forecast of 78.78 USD and a high forecast of 121.8 USD.

Lowest
Price Target
78.78 USD
115% Upside
Average
Price Target
95.37 USD
160% Upside
Highest
Price Target
121.8 USD
232% Upside
Apogee Therapeutics Inc Competitors:
Price Targets
RAPT
Rapt Therapeutics Inc
476% Upside
IGMS
IGM Biosciences Inc
51% Upside
STTK
Shattuck Labs Inc
148% Upside
ITOS
Iteos Therapeutics Inc
154% Upside
251120
Bio-FD&C Co Ltd
22% Upside
NTRA
Natera Inc
27% Upside
HALO
Halozyme Therapeutics Inc
27% Upside
RNA
Avidity Biosciences Inc
120% Upside

Revenue
Forecast

Revenue Estimate
Apogee Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Apogee Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Apogee Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APGE's stock price target?
Price Target
95.37 USD

According to Wall Street analysts, the average 1-year price target for APGE is 95.37 USD with a low forecast of 78.78 USD and a high forecast of 121.8 USD.

Back to Top